OA22.04 BRIGHTSTAR Local Consolidative Therapy with Brigatinib in Tyrosine Kinase Inhibitor-Naïve ALK-Rearranged Metastatic NSCLC
Yasir Y. Elamin, S. Gandhi, Mohammed Saad, Sadiq Rehmani, Mara B. Antonoff, Don L. Gibbons, Xiuning Le, Marcelo V. Negrão, Vincent K. Lam, Mehmet Altan, J. Tu, Carl M. Gay, Lauren A. Byers, Tina Cascone, George R. Blumenschein, Joe Y. Chang, Ara A. Vaporciyan, Zhongxing Liao, Stephen G. Swisher, Jianhua Yin, K. Park, P. Zhang, Jia Wu, John V. Heymach
Topics & Concepts
MedicineTyrosine-kinase inhibitorAcquired resistanceTyrosine kinaseOncologyCancer researchDiseaseInternal medicineResidualCancerAlgorithmReceptorComputer scienceLung Cancer Treatments and MutationsGastric Cancer Management and OutcomesColorectal Cancer Treatments and Studies